Drug (if Trial Patent No. Filed Date Petitioner(s) Patent Owner(s) Inst. Dec. Outcome Details of FWD applicable)
Oxford Nanopore UAB Research Foundation; Claims disclaimed; final IPR2015-00057 8,673,550 13-Oct-14 Technologies Ltd. The University of Washington Instituted written decision Some claims upheld Mylan Pharmaceuticals, Inc.; Mylan Laboratories Ltd.; Mylan, Inc.; Mylan Institutional Inc.; Agila Specialties Inc.; Agila IPR2015-00131 6,468,967 23-Oct-14 Specialties Private Ltd. Cubist Pharmaceuticals, Inc. N/A Settled pre-institution N/A Agila Specialties Inc.; Mylan IPR2015-00132 6,852,689 23-Oct-14 Pharmaceuticals, Inc. Cubist Pharmaceuticals, Inc. N/A Settled pre-institution N/A Mylan Pharmaceuticals, Inc.; Mylan Laboratories Ltd.; Mylan, Inc.; Mylan Institutional Inc.; Agila Specialties Inc.; Agila IPR2015-00140 8,129,342 23-Oct-14 Specialties Private Ltd. Cubist Pharmaceuticals, Inc. N/A Settled pre-institution N/A Mylan Pharmaceuticals, Inc.; Mylan Laboratories Ltd.; Mylan, Inc.; Mylan Institutional Inc.; Agila Specialties Inc.; Agila IPR2015-00141 8,058,238 23-Oct-14 Specialties Private Ltd. Cubist Pharmaceuticals, Inc. N/A Settled pre-institution N/A Mylan Pharmaceuticals, Inc.; Mylan Laboratories Ltd.; Mylan, Inc.; Mylan Institutional Inc.; Agila Specialties Inc.; Agila IPR2015-00142 8,058,238 23-Oct-14 Specialties Private Ltd. Cubist Pharmaceuticals, Inc. N/A Settled pre-institution N/A Mylan Pharmaceuticals, Inc.; Mylan Laboratories Ltd.; Mylan, Inc.; Mylan Institutional Inc.; Agila Specialties Inc.; Agila IPR2015-00143 8,058,238 23-Oct-14 Specialties Private Ltd. Cubist Pharmaceuticals, Inc. N/A Settled pre-institution N/A Mylan Pharmaceuticals, Inc.; Mylan Laboratories Ltd.; Mylan, Inc.; Mylan Institutional Inc.; Agila Specialties Inc.; Agila IPR2015-00144 8,058,238 24-Oct-14 Specialties Private Ltd. Cubist Pharmaceuticals, Inc. N/A Settled pre-institution N/A University of Utah Research IPR2015-00152 5,747,282 24-Oct-14 GeneDx, Inc. Foundation N/A Settled pre-institution N/A University of Utah Research Foundation; HSC Research and Development Limited Partnership; Trustees of the Bio-Reference Laboratories, University of Pennsylvania; IPR2015-00154 5,837,492 24-Oct-14 Inc.; GeneDx, Inc. Endorecherche N/A Settled pre-institution N/A BioDelivery Sciences IPR2015-00165 8,765,167 28-Oct-14 International, Inc. MonoSol Rx LLC Instituted Final written decision All inst. claims upheld BioDelivery Sciences IPR2015-00167 8,765,167 28-Oct-14 International, Inc. MonoSol Rx LLC Denied N/A N/A BioDelivery Sciences IPR2015-00168 8,765,167 28-Oct-14 International, Inc. MonoSol Rx LLC Instituted Final written decision All inst. claims upheld BioDelivery Sciences IPR2015-00169 8,765,167 28-Oct-14 International, Inc. MonoSol Rx LLC Instituted Final written decision All inst. claims upheld IPR2015-00170 8,076,507 28-Oct-14 Daicel Corporation Celanese International Corp. Denied N/A N/A IPR2015-00171 8,076,507 28-Oct-14 Daicel Corporation Celanese International Corp. Denied N/A N/A IPR2015-00173 8,076,507 28-Oct-14 Daicel Corporation Celanese International Corp. Denied N/AN/A IPR2015-00223 6,852,689 3-Nov-14 Fresenius Kabi USA, LLC Cubist Pharmaceuticals, Inc. Instituted Final written decision unpatentable IPR2015-00227 6,468,967 3-Nov-14 Fresenius Kabi USA, LLC Cubist Pharmaceuticals, Inc. Instituted Final written decision Some claims settled, some Merial Limited; University of Ceva Sante Animale S.A.; Saskatchewan; The Queen's IPR2015-00254 6,517,843 10-Nov-14 Biomune Company University of Belfast Instituted Claims disclaimed N/A Roche Molecular Systems, Inc.; Mayo Foundation for Medical Education and IPR2015-00255 5,643,723 10-Nov-14 Cepheid Research Denied N/A N/A Mylan, Inc.; Mylan Pharmaceuticals, Inc.; Mylan LTS Lohmann Therapie- IPR2015-00265 Exelon® 6,316,023 13-Nov-14 Technologies, Inc. Systeme AG; Novartis AG Instituted Final written decision All inst. claims unpatentable Mylan Technolgies, Inc; Mylan Pharmaceuticals, Inc.; Mylan, Novartis AG; LTS Lohmann IPR2015-00268 Exelon® 6,335,031 13-Nov-14 Inc. Therapie-Systeme AG Instituted Final written decision All inst. claims unpatentable ALETHIA BIOTHERAPEUTICS IPR2015-00291 8,168,181 25-Nov-14 Daiichi Sankyo Co., Ltd. INC. Instituted Final written decision All inst. claims unpatentable Rinat Neuroscience Corp.; IPR2015-00293 8,173,127 24-Nov-14 Pfizer, Inc. Intellect Neurosciences, Inc. N/A Settled pre-institution N/A Tissue Transplant Technology, Ltd.; Human Biologics of IPR2015-00320 8,709,494 1-Dec-14 Texas, Ltd. MiMedx Group, Inc. Denied N/A N/A IPR2015-00405 Lexiva® 6,436,989 10-Dec-14 Lupin Ltd. Vertex Pharmaceuticals Inc. Instituted Claims disclaimed N/A Namenda XR®; Ranbaxy Inc.; Ranbaxy IPR2015-00410 Namzaric™ 8,362,085 18-Dec-14 Laboratories Ltd. Adamas Pharmaceuticals Inc. N/A Settled pre-institution N/A Boehringer Ingelheim International GMBH; Boehringer Ingelheim Biogen Idec, Inc.; Genentech, IPR2015-00415 Rituxan™ 7,820,161 15-Dec-14 Pharmaceuticals, Inc. Inc. Instituted Claims disclaimed N/A Boehringer Ingelheim International GMBH; Boehringer Ingelheim Biogen Idec, Inc.; Genentech, IPR2015-00417 Rituxan™ 7,976,838 15-Dec-14 Pharmaceuticals, Inc. Inc. Instituted Claims disclaimed N/A Boehringer Ingelheim International GMBH; Boehringer Ingelheim Biogen Idec, Inc.; Genentech, IPR2015-00418 Rituxan™ 8,329,172 15-Dec-14 Pharmaceuticals, Inc. Inc. Denied N/A N/A Apotex Holdings, Inc.; Apotex IPR2015-00419 Emend® 5,691,336 11-Dec-14 Inc. Merck Sharp & Dohme Corp. Denied N/A N/A Tissue Transplant Technology, Ltd.; Human Biologics of IPR2015-00420 8,597,687 11-Dec-14 Texas, Ltd. MiMedx Group, Inc. Instituted Final written decision All inst. claims unpatentable Mylan, Inc.; Onco Therapies Ltd.; Agila Specialties Inc.; IPR2015-00503 Treanda® 8,436,190 24-Dec-14 Mylan Laboratories Ltd. Cephalon, Inc. Instituted Settled post-institution N/A Mylan Pharmaceuticals, Inc.; Mitsubishi Pharma Corp.; IPR2015-00518 Gilenya™ 8,324,283 31-Dec-14 Apotex Inc. Novartis AG Instituted Final written decision All inst. claims unpatentable Praxair, Inc.; Praxair IPR2015-00522 INOmax® 8,282,966 5-Jan-15 Distribution, Inc. INO Therapeutics LLC Denied N/A N/A Praxair, Inc.; Praxair IPR2015-00524 INOmax® 8,293,284 5-Jan-15 Distribution, Inc. INO Therapeutics LLC Denied N/A N/A Praxair, Inc.; Praxair IPR2015-00525 INOmax® 8,431,163 5-Jan-15 Distribution, Inc. INO Therapeutics LLC Denied N/A N/A Praxair, Inc.; Praxair IPR2015-00526 INOmax® 8,795,741 5-Jan-15 Distribution, Inc. INO Therapeutics LLC Denied N/A N/A Praxair, Inc.; Praxair IPR2015-00529 INOmax® 8,846,112 5-Jan-15 Distribution, Inc. INO Therapeutics LLC Instituted Final written decision Some claims upheld Trizivir®; Epzicom®; Teva Pharmaceuticals USA, ViiV Healthcare Company; Viiv IPR2015-00550 Triumeq® 6,417,191 8-Jan-15 Inc. Healthcare UK Ltd. Denied Time barred N/A Boston Heart Diagnostics Health Diagnostic Laboratory, IPR2015-00557 8,119,358 13-Jan-15 Corp. Inc. Denied N/A N/A Cialis®; IPR2015-00561 Adcirca® 7,182,958 13-Jan-15 Actelion Pharmaceuticals Ltd. ICOS Corp. Instituted Final written decision All inst. claims unpatentable Cialis®; IPR2015-00562 Adcirca® 6,821,975 13-Jan-15 Actelion Pharmaceuticals Ltd. ICOS Corp. Instituted Final written decision All inst. claims unpatentable Amneal Pharmaceuticals LLC; Mylan Pharmaceuticals, Inc.; Mylan Teoranta; Mylan Inc.; Amneal Pharmaceuticals Co. Yeda Research and IPR2015-00643 Copaxone® 8,232,250 6-Feb-15 GmbH Development Co. Ltd. Instituted Final written decision All inst. claims unpatentable Amneal Pharmaceuticals LLC; Mylan Pharmaceuticals, Inc.; Mylan Teoranta; Mylan Inc.; Amneal Pharmaceuticals Co. Yeda Research and IPR2015-00644 Copaxone® 8,399,413 7-Feb-15 GmbH Development Co. Ltd. Instituted Final written decision All inst. claims unpatentable Musculoskeletal Transplant Foundation; Liventa Bioscience, Inc.; Medline IPR2015-00664 8,372,437 2-Feb-15 Industries, Inc. MiMedx Group, Inc. Instituted Final written decision All inst. claims unpatentable
Musculoskeletal Transplant Foundation; Liventa Bioscience, Inc.; Medline IPR2015-00669 8,323,701 2-Feb-15 Industries, Inc. MiMedx Group, Inc. Denied N/A N/A LO Loestrin® Mylan, Inc.; Mylan FE; LO Pharmaceuticals, Inc.; US Warner Chicott (US), LLC; IPR2015-00682 Minastrin® FE 7,704,984 3-Feb-15 Family Care Walter-Chilcott Co. LLC N/A Settled pre-institution N/A IPR2015-00715 Diprivan® 8,476,010 6-Feb-15 Dr. Reddy's Laboratories, Inc. Fresenius Kabi USA, LLC N/A Settled pre-institution N/A J Kyle Bass; Hayman Credes IPR2015-00720 Ampyra® 8,663,685 10-Feb-15 Master Fund, LP; et al. Acorda Therapeutics Inc. Denied N/A N/A Takeda Pharmaceutical Co. IPR2015-00754 8,592,454 17-Feb-15 Array Biopharma Inc. Ltd. Instituted Final written decision All inst. claims unpatentable
Dr. Reddy's Laboratories, Inc.; Horizon Pharma PLC; Pozen IPR2015-00802 Vimovo® 8,557,285 24-Feb-15 Dr. Reddy's Laboratories, Ltd. Inc. Denied N/A N/A J Kyle Bass; Hayman Credes IPR2015-00817 Ampyra® 8,007,826 27-Feb-15 Master Fund, LP; et al. Acorda Therapeutics Inc. Denied N/A N/A Amneal Pharmaceuticals LLC; Mylan Pharmaceuticals, Inc.; Mylan Teoranta; Mylan Inc.; Mylan N.V.; Amneal Yeda Research and IPR2015-00830 Copaxone® 8,969,302 3-Mar-15 Pharmaceuticals Co. GmbH Development Co. Ltd. Instituted Final written decision All inst. claims unpatentable IPR2015-00858 Combigan® 7,030,149 9-Mar-15 Ferrum Ferro Capital, LLC Allergan Sales, LLC Denied N/A N/A Cadila Healthcare Ltd.; Amneal Pharmaceuticals LLC; Dr. Reddy's Laboratories, Inc.; Ube Industries, Ltd.; Daiichi IPR2015-00864 Effient® 8,404,703 12-Mar-15 et al. Sankyo Co., Ltd. Instituted Final written decision All inst. claims unpatentable Glenmark Generics Ltd.; Cadila Healthcare Ltd.; Apotex Ube Industries, Ltd.; Daiichi IPR2015-00865 Effient® 8,569,325 13-Mar-15 Inc.; et al. Sankyo Co., Ltd. Instituted Final written decision All inst. claims unpatentable Apotex Holdings, Inc.; Apotex IPR2015-00873 Tygacil® 7,879,828 12-Mar-15 Inc. Wyeth LLC Denied N/A N/A Roche Molecular Systems, Inc.; Mayo Foundation for Medical Education and IPR2015-00881 5,643,723 13-Mar-15 Cepheid Research Instituted Claims disclaimed N/A InnoPharma LLC; Inno Pharma Licensing LLC; Lupin Senju Pharmaceutical Co. Ltd.; Pharmaceuticals, Inc.; Bausch & Lomb Inc.; Bausch & IPR2015-00902 Prolensa™ 8,669,290 19-Mar-15 InnoPharma Inc.; et al. Lomb Pharma Holdings Corp. Instituted Final written decision All inst. claims upheld InnoPharma LLC; Inno Pharma Licensing LLC; Mylan Senju Pharmaceutical Co. Ltd.; Pharmaceuticals, Inc.; Mylan, Bausch & Lomb Inc.; Bausch & IPR2015-00903 Prolensa™ 8,129,431 19-Mar-15 Inc.; et al. Lomb Pharma Holdings Corp. Instituted Final written decision All inst. claims upheld Arkema Inc.; Arkema S.A.; IPR2015-00915 8,710,282 20-Apr-15 Arkema France Honeywell Internationa, Inc. Instituted Final written decision All inst. claims upheld Arkema Inc.; Arkema S.A.; IPR2015-00916 8,710,282 20-Apr-15 Arkema France Honeywell Internationa, Inc. Instituted Final written decision All inst. claims upheld Arkema Inc.; Arkema S.A.; IPR2015-00917 8,710,282 20-Apr-15 Arkema France Honeywell Internationa, Inc. Instituted Final written decision All inst. claims upheld Baxter Healthcare S.A.; Baxter IPR2015-00945 6,066,325 26-Mar-15 Ethicon, Inc. International, Inc. N/A Settled pre-institution N/A Ethicon, Inc.; Johnson & Baxter Healthcare S.A.; Baxter IPR2015-00952 8,603,511 26-Mar-15 Johnson International, Inc. N/A Settled pre-institution N/A Ethicon, Inc.; Johnson & Baxter Healthcare S.A.; Baxter IPR2015-00953 8,357,378 26-Mar-15 Johnson International, Inc. N/A Settled pre-institution N/A Ethicon, Inc.; Johnson & Baxter Healthcare S.A.; Baxter IPR2015-00954 8,303,981 26-Mar-15 Johnson International, Inc. N/A Settled pre-institution N/A Ethicon, Inc.; Johnson & Baxter Healthcare S.A.; Baxter IPR2015-00955 8,512,729 26-Mar-15 Johnson International, Inc. N/A Settled pre-institution N/A Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-00988 Lialda® 6,773,720 1-Apr-15 al. Cosmo Technologies Ltd. Instituted Final written decision All inst. claims upheld Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-00990 Gattex® Kit 7,056,886 1-Apr-15 al. N P S Pharmaceuticals Inc. Instituted Final written decision All inst. claims unpatentable Acreto Agricultural Chemicals IPR2015-01016 8,791,049 6-Apr-15 Corp. Gowan, Inc. Denied Procedurally dismissed N/A Prezista®; Lupin Pharmaceuticals, Inc.; IPR2015-01030 Prezcobix™ 8,518,987 9-Apr-15 Lupin Ltd. Janssen Sciences Ireland UC Denied N/A N/A Mylan Inc.; Mylan Nissan Chemical Industries, IPR2015-01069 Livalo® 5,856,336 18-Apr-15 Pharmaceuticals, Inc. Ltd. Denied N/A N/A J Kyle Bass; Hayman Credes IPR2015-01076 Imbruvica® 8,754,090 20-Apr-15 Master Fund, LP; et al. Pharmacyclics LLC N/A Settled pre-institution N/A Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-01086 Tecfidera® 8,759,393 22-Apr-15 al. Biogen International GmbH Denied N/A N/A Roche Molecular Systems, Inc.; F Hoffman-La Roche Ltd.; IPR2015-01091 7,955,794 24-Apr-15 Roche Holding Ltd. Illumina, Inc. Denied N/A N/A Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-01093 Gattex® Kit 7,056,886 23-Apr-15 al. N P S Pharmaceuticals Inc. Instituted Final written decision All inst. claims unpatentable InnoPharma LLC; InnoPharma Licensing LLC; Lupin Pharmaceuticals, Inc.; InnoPharma Inc.; Mylan Pharmaceuticals, Inc.; Mylan, Inc.; InnoPharma Licensing, IPR2015-01097 Prolensa™ 8,754,131 23-Apr-15 Inc.; Lupin Ltd. Senju Pharmaceutical Co. Ltd. Instituted Final written decision All inst. claims upheld Lupin Pharmaceuticals, Inc.; IPR2015-01099 Prolensa™ 8,669,290 23-Apr-15 Lupin Ltd. Senju Pharmaceutical Co. Ltd. Instituted Final written decision All inst. claims upheld InnoPharma LLC; InnoPharma Licensing LLC; Lupin Pharmaceuticals, Inc.; IPR2015-01100 Prolensa™ 8,927,606 23-Apr-15 InnoPharma Inc.; et al. Senju Pharmaceutical Co. Ltd. Instituted Final written decision All inst. claims upheld InnoPharma LLC; InnoPharma Licensing LLC; Lupin Pharmaceuticals, Inc.; IPR2015-01105 Prolensa™ 8,871,813 23-Apr-15 InnoPharma Inc.; et al. Senju Pharmaceutical Co. Ltd. Instituted Final written decision All inst. claims upheld IPR2015-01109 7,087,397 24-Apr-15 Infopia Co., Ltd. Polymeric Technology, Inc. Denied N/A N/A Lupin Ltd.; Lupin Pharmaceuticals, Inc.; Par Horizon Therapeutics, Inc.; IPR2015-01117 Ravicti® 8,642,012 29-Apr-15 Pharmaceutical Inc. Hyperion Therapeutics Inc. Instituted Final written decision All inst. claims upheld Galderman Laboratories LP; Galderma SA; Nestle Skin Health, Inc.; Galderma Laboratories Inc.; Galderma IPR2015-01119 7,148,041 29-Apr-15 Res. & Dev't SNC Allergan, Inc. Instituted Claims disclaimed N/A Par Pharmaceutical Inc.; Lupin Pharmaceuticals, Inc.; Lupin Horizon Therapeutics, Inc.; IPR2015-01127 Ravicti® 8,404,215 29-Apr-15 Ltd. Hyperion Therapeutics Inc. Instituted Final written decision All inst. claims unpatentable Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-01136 Tecfidera® 8,399,514 1-May-15 al. Biogen MA Inc. Denied N/A N/A Coalition for Affordable Drugs IPR2015-01169 8,635,517 7-May-15 VI LLC Celgene Corporation Denied N/A N/A Polymer Technology Systems, IPR2015-01192 7,087,397 12-May-15 Infopia Co., Ltd. Inc. Denied N/A N/A Senju Pharmaceutical Co.; IPR2015-01205 Durezol® 6,114,319 15-May-15 Akorn, Inc. Mitsubishi Chemical Corp. Instituted Final written decision All inst. claims unpatentable Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Vimovo®; Spangenberg; J Kyle Bass; et IPR2015-01241 Yosprala® 6,926,907 21-May-15 al. Pozen Inc. Denied N/A N/A Apotex, Inc.; Apotex Holdings, IPR2015-01278 Restasis® 8,633,162 4-Jun-15 Inc. Allergan, Inc. N/A Settled pre-institution N/A Apotex, Inc.; Apotex Holdings, IPR2015-01282 Restasis® 8,629,111 4-Jun-15 Inc. Allergan, Inc. N/A Settled pre-institution N/A Apotex, Inc.; Apotex Holdings, IPR2015-01283 Restasis® 8,685,930 4-Jun-15 Inc. Allergan, Inc. N/A Settled pre-institution N/A Apotex, Inc.; Apotex Holdings, IPR2015-01284 Restasis® 8,648,048 4-Jun-15 Inc. Allergan, Inc. N/A Settled pre-institution N/A Apotex, Inc.; Apotex Holdings, IPR2015-01286 Restasis® 8,642,556 4-Jun-15 Inc. Allergan, Inc. N/A Settled pre-institution N/A IPR2015-01305 8,048,414 29-May-15 Bioactive Laboratories BTG International Inc. Denied N/A N/A GKC General Partner II, LLC; Gerchen Keller Capital, LLC; Neptune Generics, LLC; GKC Partners II, LP; Niagara IPR2015-01313 7,456,317 29-May-15 FundingCo, LLC AUSPEX Pharmaceuticals, Inc. Denied N/A N/A Onglyza™; Kombiglyze® IPR2015-01340 XR; Qtern® RE44186 4-Jun-15 Mylan Pharmaceuticals, Inc. Astrazeneca AB Instituted Final written decision All inst. claims upheld Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-01344 Vimovo® 8,858,996 5-Jun-15 al. Pozen Inc. Denied N/A N/A Final written decision; IPR2015-01490 Injectafer® 7,754,702 24-Jun-15 Pharmacosmos A/S Luitpold Pharmaceuticals, Inc. Instituted claims disclaimed All inst. claims unpatentable Daiichi Sankyo Co., Ltd.; Ube IPR2015-01492 Effient® 8,569,325 26-Jun-15 Panacea Biotec Ltc. Industries, Ltd. Denied N/A N/A Final written decision; IPR2015-01493 8,431,549 24-Jun-15 Pharmacosmos A/S Luitpold Pharmaceuticals, Inc. Instituted claims disclaimed All inst. claims unpatentable
IPR2015-01495 Injectafer® 8,895,612 24-Jun-15 Pharmacosmos A/S Luitpold Pharmaceuticals, Inc. Denied N/A N/A Daiichi Sankyo Co., Ltd.; Ube IPR2015-01496 Effient® 8,404,703 26-Jun-15 Panacea Biotec Ltc. Industries, Ltd. Denied N/A N/A IPR2015-01514 Humira® 8,916,157 26-Jun-15 Amgen Inc. AbbVie Biotechnology Ltd. Denied N/A N/A IPR2015-01517 Humira® 8,916,158 26-Jun-15 Amgen Inc. AbbVie Biotechnology Ltd. Denied N/A N/A Momenta Pharmaceuticals, IPR2015-01537 Orencia® 8,476,239 2-Jul-15 Inc. Bristol-Myers Squibb Co. Instituted Final written decision All inst. claims upheld
Dr. Reddy's Laboratories, Inc.; Roche Palo Alto LLC; Helsinn IPR2015-01550 Aloxi® 8,729,094 3-Jul-15 Dr. Reddy's Laboratories, Ltd. Healthcare S.A. N/A Settled pre-institution N/A
Dr. Reddy's Laboratories, Inc.; Roche Palo Alto LLC; Helsinn IPR2015-01551 Aloxi® 8,729,094 3-Jul-15 Dr. Reddy's Laboratories, Ltd. Healthcare S.A. N/A Settled pre-institution N/A
Dr. Reddy's Laboratories, Inc.; Roche Palo Alto LLC; Helsinn IPR2015-01553 Aloxi® 8,729,094 3-Jul-15 Dr. Reddy's Laboratories, Ltd. Healthcare S.A. N/A Settled pre-institution N/A Dr. Reddy's Laboratories, Inc.; Roche Palo Alto LLC; Helsinn IPR2015-01554 Aloxi® 8,729,094 3-Jul-15 Dr. Reddy's Laboratories, Ltd. Healthcare S.A. N/A Settled pre-institution N/A IPR2015-01566 8,129,342 10-Jul-15 Fresenius Kabi USA, LLC Cubist Pharmaceuticals, Inc. N/A Settled pre-institution N/A IPR2015-01570 8,058,238 10-Jul-15 Fresenius Kabi USA, LLC Cubist Pharmaceuticals, Inc. N/A N/A N/A IPR2015-01571 8,058,238 10-Jul-15 Fresenius Kabi USA, LLC Cubist Pharmaceuticals, Inc. N/A N/A N/A IPR2015-01572 8,058,238 10-Jul-15 Fresenius Kabi USA, LLC Cubist Pharmaceuticals, Inc. N/A Settled pre-institution N/A Hydrite Chemical International Co.; Hydrite Chemical Co.; Hydrite IPR2015-01586 8,841,469 14-Jul-15 Advanced Resins LLC Solenis Technologies, LP Instituted Settled post-institution N/A IPR2015-01593 8,679,524 14-Jul-15 Dermira, Inc. PUREPHARM INC. Instituted Final written decision Some claims upheld IPR2015-01594 8,252,316 14-Jul-15 Dermira, Inc. PUREPHARM INC. Instituted Final written decision Some claims upheld Sanofi-Aventix U.S. LLC; Regeneron Pharmaceuticals, Inc.; Genzyme Corp.; Sanofi IPR2015-01624 6,331,415 27-Jul-15 S.A. City of Hope; Genentech, Inc. Instituted Settled post-institution N/A Lannett Holdings Inc.; Lannett IPR2015-01629 Zomig® 6,750,237 28-Jul-15 Co., Inc. Astrazeneca AB Denied Time barred N/A Lannett Holdings Inc.; Lannett IPR2015-01630 Zomig® 7,220,767 28-Jul-15 Co., Inc. Astrazeneca AB Denied Time barred N/A Sawai USA, Inc.; Sawai Nissan Chemical Industries, IPR2015-01647 Livalo® 5,856,336 31-Jul-15 Pharmaceutical Co., Ltd. Ltd. Denied N/A N/A Sawai USA, Inc.; Sawai Nissan Chemical Industries, IPR2015-01648 Livalo® 5,856,336 31-Jul-15 Pharmaceutical Co., Ltd. Ltd. Denied N/A N/A Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-01680 Vimovo® 8,852,636 7-Aug-15 al. Pozen Inc. Denied N/A N/A Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-01718 Vimovo® 8,945,621 12-Aug-15 al. Pozen Inc. Instituted Final written decision All inst. claims upheld Sloan Kettering Institute for IPR2015-01719 7,446,190 13-Aug-15 Kite Pharma, Inc. Cancer Research Instituted Final written decision All inst. claims upheld Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-01723 Eliquis® 6,967,208 13-Aug-15 al. Bristol-Myers Squibb Co. Denied N/A N/A IPR2015-01733 Rituxan™ 7,976,838 14-Aug-15 Celltrion, Inc. Genentech, Inc. N/A Procedurally dismissed N/A IPR2015-01744 Rituxan™ 7,820,161 17-Aug-15 Celltrion, Inc. Genentech, Inc. N/A Procedurally dismissed N/A IPR2015-01767 6,017,221 18-Aug-15 Lam Research Corp. Daniel L. Flamm Instituted Settled post-institution N/A Lupin Pharmaceuticals, Inc.; IPR2015-01773 Vimovo® 8,858,996 19-Aug-15 Lupin Ltd. Pozen Inc. Instituted Final written decision All inst. claims upheld Lupin Pharmaceuticals, Inc.; IPR2015-01774 Vimovo® 8,852,636 19-Aug-15 Lupin Ltd. Pozen Inc. Denied N/A N/A Lupin Pharmaceuticals, Inc.; IPR2015-01775 8,865,190 19-Aug-15 Lupin Ltd. Pozen Inc. Instituted Final written decision All inst. claims upheld Coalition for Affordable Drugs X LLC; Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich IPR2015-01776 Kerydin® 7,582,621 20-Aug-15 Spangenberg; et al. Anacor Pharmaceuticals, Inc. Instituted Final written decision All inst. claims unpatentable
Dr. Reddy's Laboratories, Inc.; IPR2015-01777 Oracea® 8,603,506 20-Aug-15 Dr. Reddy's Laboratories, Ltd. Galderma Laboratories Inc. Denied N/A N/A
Dr. Reddy's Laboratories, Inc.; IPR2015-01778 Oracea® 8,603,506 20-Aug-15 Dr. Reddy's Laboratories, Ltd. Galderma Laboratories Inc. Denied N/A N/A Coalition for Affordable Drugs X LLC; Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich IPR2015-01780 7,767,657 20-Aug-15 Spangenberg; et al. Anacor Pharmaceuticals, Inc. Instituted Final written decision All inst. claims unpatentable
Dr. Reddy's Laboratories, Inc.; IPR2015-01782 Oracea® 8,603,506 20-Aug-15 Dr. Reddy's Laboratories, Ltd. Galderma Laboratories Inc. Denied N/A N/A Coalition for Affordable Drugs X LLC; Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich IPR2015-01785 7,767,657 20-Aug-15 Spangenberg; et al. Anacor Pharmaceuticals, Inc. Instituted Final written decision All inst. claims unpatentable Coalition for Affordable Drugs V LLC; Hayman Orange Fund SPC - Portfolio A; Hayman Offshore Management, Inc.; Amgen Inc.; Hoffman-La IPR2015-01792 Enbrel® 8,163,522 22-Aug-15 et al. Roche Inc.; Immunex Corp. Denied N/A N/A Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-01797 Subsys® 8,835,459 24-Aug-15 al. Insys Pharma, Inc. Denied N/A N/A LaCore Enterprises; PruvIT IPR2015-01798 6,613,356 24-Aug-15 Ventures, Inc. VND Butyrate LLC Instituted Settled post-institution N/A Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-01799 Subsys® 8,835,460 24-Aug-15 al. Insys Pharma, Inc. Denied N/A N/A Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-01800 Subsys® 8,486,972 24-Aug-15 al. Insys Pharma, Inc. Denied N/A N/A Hayman Investmens, LLC; Hayman Orange Fund SPC - Portfolio A; Erich Trustees of the University of IPR2015-01835 Juxtapid® 8,618,135 28-Aug-15 Spangenberg; et al. Pennsylvania Instituted Final written decision All inst. claims upheld Hayman Investmens, LLC; Hayman Orange Fund SPC - Portfolio A; Erich Trustees of the University of IPR2015-01836 Juxtapid® 7,932,268 28-Aug-15 Spangenberg; et al. Pennsylvania Instituted Final written decision All inst. claims upheld EI Dupont De Nemours and Co.; Archer Daniels Midland IPR2015-01838 8,865,921 28-Aug-15 Co. FURANIX TECHNOLOGIES B.V. Instituted Final written decision All inst. claims upheld Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-01850 Ampyra® 8,440,703 2-Sep-15 al. Acorda Therapeutics Inc. Instituted Final written decision All inst. claims upheld Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-01853 Ampyra® 8,007,826 2-Sep-15 al. Acorda Therapeutics Inc. Instituted Final written decision All inst. claims upheld Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-01857 Ampyra® 8,663,685 3-Sep-15 al. Acorda Therapeutics Inc. Instituted Final written decision All inst. claims upheld Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-01858 Ampyra® 8,354,437 3-Sep-15 al. Acorda Therapeutics Inc. Instituted Final written decision All inst. claims upheld Lupin Pharmaceuticals, Inc.; IPR2015-01871 Prolensa™ 8,129,431 4-Sep-15 Lupin Ltd. Senju Pharmaceutical Co. Ltd. Instituted Final written decision All inst. claims upheld Lupin Pharmaceuticals, Inc.; Daiichi Sankyo Co., Ltd.; Ube IPR2015-01881 8,569,325 5-Oct-15 Lupin Ltd. Industries, Ltd. Instituted Final written decision All inst. claims unpatentable Lupin Pharmaceuticals, Inc.; Daiichi Sankyo Co., Ltd.; Ube IPR2015-01882 8,404,703 5-Oct-15 Lupin Ltd. Industries, Ltd. Instituted Final written decision All inst. claims unpatentable Horizon Discovery Group PLC; Horizon Sage Holding Corp.; Trasposagen IPR2015-01884 8,558,055 8-Sep-15 Sage Labs, Inc. Biopharmaceuticals, Inc. N/A Settled pre-institution N/A Horizon Discovery Group PLC; Horizon Sage Holding Corp.; Trasposagen IPR2015-01887 8,722,964 8-Sep-15 Sage Labs, Inc. Biopharmaceuticals, Inc. N/A Settled pre-institution N/A Amneal Pharmaceuticals LLC; Mylan Pharmaceuticals, Inc.; Amneal Pharmaceuticals Co. Yeda Research and IPR2015-01976 Copaxone® 8,232,250 25-Sep-15 GmbH Development Co. Ltd. Instituted Final written decision All inst. claims unpatentable Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals Co. Yeda Research and IPR2015-01980 Copaxone® 8,399,413 25-Sep-15 GmbH Development Co. Ltd. Instituted Final written decision All inst. claims unpatentable Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals Co. Yeda Research and IPR2015-01981 Copaxone® 8,969,302 25-Sep-15 GmbH Development Co. Ltd. Instituted Final written decision All inst. claims unpatentable Hayman Orange Fund SPC; Hayman Credes Master Fund, LP; Hayman Offshore Management, Inc.; Erich Spangenberg; J Kyle Bass; et IPR2015-01993 Tecfidera® 8,399,514 28-Sep-15 al. Biogen MA Inc. Instituted Final written decision All inst. claims upheld Mylan N.V.; Mylan Pharma U.K. Ltd.; Mylan Pharmaceuticals, Inc.; Mylan, Claims disclaimed; settled in IPR2015-02002 Flovent® HFA 6,743,413 29-Sep-15 Inc. 3M Company Instituted part N/A Adderall XR®; Amerigen Pharmaceuticals IPR2015-02009 Mydayis® RE42096 1-Oct-15 Ltd. Shire LLC Instituted Final written decision Claims amended